KR970032820A - 자외선 차단제를 함유하는 피부상처 치료제의 제조방법 - Google Patents

자외선 차단제를 함유하는 피부상처 치료제의 제조방법 Download PDF

Info

Publication number
KR970032820A
KR970032820A KR1019950047411A KR19950047411A KR970032820A KR 970032820 A KR970032820 A KR 970032820A KR 1019950047411 A KR1019950047411 A KR 1019950047411A KR 19950047411 A KR19950047411 A KR 19950047411A KR 970032820 A KR970032820 A KR 970032820A
Authority
KR
South Korea
Prior art keywords
benzophenone
wound healing
mixing
paba
ultraviolet
Prior art date
Application number
KR1019950047411A
Other languages
English (en)
Other versions
KR0153202B1 (ko
Inventor
김종일
Original Assignee
이능희
주식회사 태평양
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이능희, 주식회사 태평양 filed Critical 이능희
Priority to KR1019950047411A priority Critical patent/KR0153202B1/ko
Publication of KR970032820A publication Critical patent/KR970032820A/ko
Application granted granted Critical
Publication of KR0153202B1 publication Critical patent/KR0153202B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/29—Titanium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

본 발명은 피부의 상처를 치료능이 우수한 조성물의 제조방법에 관한 것이고, 이 제조방법은 베이스 성분; 자외선 산란제와 자외선 흡수제로 된 자외선 차단체; 상처치유제 및 물을 함유하는 상처 치유제 조성물의 제조방법에 있어서, (a) 베이스 성분과 자외선 흡수제를 혼합하여 가열하여 용융하는 단계; (b)단계 (a)에서 얻은 용융 혼합물에 자외선 산란제를 첨가하여 혼합하는 단계; (c) 물을 70~90℃로 가열한 후 상기 (b) 단계의 혼합물에 첨가하여 혼합하는 단계; 및 (d) 상기 (c) 단계에서 얻은 혼합물에 상처 치유제를 첨가하여 혼합하는 단계를 포함하는 것을 특징으로 한다.
상기 방법에 의해 얻어진 조성물은 물리화학적 물성이 상이한 자외선 차단제와 상처 치유제 성분이 잘 혼합되어 피부 상처에 사용시 효과적인 피부 상처 치유효과를 나타낸다.

Description

자외선 차단제를 함유하는 피부상처 치료제의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (4)

  1. 베이스 성분; 자외선 산란제와 자외선 흡수제로 된 자외선 차단제; 상처 치유제 및 물을 함유하는 상처 치유제 조성물의 제조방법에 있어서, 하기 단계; (a) 베이스 성분과 자외선 흡수제를 혼합하여 가열하에 용융하는 단계; (b) 단계(a)에서 얻은 용융 혼합물에 자외선 산란제를 첨가하여 혼합하는 단계; (c) 물을 70~90℃로 가열한 후 상기 (b) 단계의 혼합믈에 첨가하여 혼합하는 단계 ; 및 (d) 상기 (c) 단계에서 얻은 혼합물에 상처 치유제를 첨가하여 혼합하는 단계를 포함하는 특징으로 하는 상처 치유제 조성물의 제조방법.
  2. 제1항에 있어서, 상기 자외선 흡수제는 알란토인 파바(allantoin PAPB), 3,4-메틸벤질리덴 캄포(3,4-Methylbenzylidene Camphor), 시녹세이트(Chinoxate), DEA-메톡시신나메이트(DEA-Methoxycinnamate), 옥토크릴렌(Octocrylene) 벤조페논-1(Benzophenone-1), 벤조페논-2(Benzophenone-2), 벤조페논-3(Benzophenone-3), 벤조페논-4(Benzophenone-4), 벤조페논-5(Benzophenone-5), 벤노페논-6(Benzophenone-6), 벤조페논-7(Benzophenone-7), 벤조페논-8(Benzophenone-8), 벤조페논-11(Benzophenone-11), 옥트리졸(Octrizole), 옥틸디 메칠 파바(Octyl Dimethyl PABA), 옥틸메톡시신나메이트(Octyl Methoxycinnamate), 에칠 디하드록시프로필 파바(Ethyl Dihydroxypropyl PABA), 파바(PABA), PEG-25 파바(PEG-25 PABA), 펜틸디메칠 파바(Pentyl Dimethyl PABA), 페닐벤지미다졸설포닉애씨드(Phenylbenzimidazole Sulfonic Acie). 글리세릴 파바(Glyceryl PABA). 글리콜실리케이트(Glycolsalicylate), 소디움유로케네이트(Sodium Urocanate), 벤조페논-12(Benzophenone-12), 호모살레이트(Homosalate), TEA-살리실레이트(TEA-Salicylate), 3-벤조페논캄포(3-Benzophenone Camphor), 이소아밀 파라-메톡시신나메이트(Isoamyl P-Methoxycinnamate), 벤질살리실레이트(Benzyl Salicylate), 이소프로필벤질살리실레이트(Isopropylbenzyl Salicyiate). 유로켄산(Urocanic Acid). 이소프로필메톡시신나메이트(Isopropyl Methozycinnamate), 및 부틸메톡시벤조일메탄(Butyl methoxydibenzoylmethane)에서 선택된 1종 또는 2종 이상의 것임을 특징으로 하는 방법.
  3. 제1항에 있어서, 상기 자외선 산란제는 탈크(talc), 이산회티탄(titanium dioxide), 산화 아연(zinc oxide), 및 카올린(kaolin) 에서 선택된 1종 또는 2종 이상임을 특징으로 하는 방법.
  4. 제1항에 있어서, 상기 상처 치유제는 센텔라 아시아티카 추출물(centella asiatica extract), 소디움 후시데이트(sodium fusidate), 히드로코티존 아세테이트(hydrocortisone acetate), 텍사판텐놀(dexapathenol). 알란토인(allantoin), 네오마이신 셀페이트(neomycin sulfate), 젠타마이신(gentamicin sulfate), 박시트라신(bacitracin), 폴리미신 비 셀페이트(Polymyxin B sulfate), 니트로후라존(nitro furazone), 및 옥시테트라사이클린 염산(oxytetracycline HCI)에서 선택된 1종 또는 2종 이상임을 특징으로 하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019950047411A 1995-12-07 1995-12-07 자외선 차단제를 함유하는 피부상처 치료제의 제조방법 KR0153202B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019950047411A KR0153202B1 (ko) 1995-12-07 1995-12-07 자외선 차단제를 함유하는 피부상처 치료제의 제조방법

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019950047411A KR0153202B1 (ko) 1995-12-07 1995-12-07 자외선 차단제를 함유하는 피부상처 치료제의 제조방법

Publications (2)

Publication Number Publication Date
KR970032820A true KR970032820A (ko) 1997-07-22
KR0153202B1 KR0153202B1 (ko) 1998-11-16

Family

ID=19438266

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950047411A KR0153202B1 (ko) 1995-12-07 1995-12-07 자외선 차단제를 함유하는 피부상처 치료제의 제조방법

Country Status (1)

Country Link
KR (1) KR0153202B1 (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102470802B1 (ko) 2021-11-24 2022-11-28 재영티에스(주) 어스앵커용 천공장치

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102004208B1 (ko) * 2017-10-30 2019-07-29 주식회사 애니테이프 자외선 차단 기능이 있는 하이드로-콜로이드 핫멜트 습윤성 드레싱 테이프의 제조 방법

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102470802B1 (ko) 2021-11-24 2022-11-28 재영티에스(주) 어스앵커용 천공장치

Also Published As

Publication number Publication date
KR0153202B1 (ko) 1998-11-16

Similar Documents

Publication Publication Date Title
CN105813626B (zh) 含有碳二亚胺类化合物的组合物
EP0165329B1 (en) Liquid detergent with sunscreen agent
US5753244A (en) Method and product for applying skin treatments and ointments
US5744125A (en) Cosmetic melanins
WO2017034367A2 (ko) 표면 개질용 조성물
PL316416A1 (en) Pharmaceutic agent exhibiting immunoregulating and psychotropic properties, therapeutic form thereof and method of treating diseases of immunological and physical background
KR102401790B1 (ko) 피부 표면 개질용 조성물
CA2298238A1 (en) Controlled release by extrusion of solid amorphous dispersions of drugs
CA2214884A1 (en) Poly(hydroxy acid)/polymer conjugates for skin applications
JP2002506099A (ja) 酵素阻害剤
EP0921819A4 (en) CANCER TREATMENT AND PREVENTION THROUGH DERIVATIVES OF HUMAN CHORIO-GONADOTROPINE
JP2003522726A (ja) 着色した毛髪を処理する化粧方法
CA2391343A1 (en) Skin care composition
US4933174A (en) Method of using a liquid detergent with sunscreen agent
EP1090642A3 (en) Vaccines comprising a polysaccharide antigen-carrier protein conjugate and free carrier protein
NO20010593L (no) Preparat og fremgangsmÕte for behandling av Peyronies sykdom og andre subdermale plakkmanifestasjonsforstyrrelser
WO1996025920A9 (en) Cosmetic melanins
DE69418601D1 (de) Guanidinderivate mit therapeutischer wirkung
EP0996412A1 (en) Sunscreen composition
KR970032820A (ko) 자외선 차단제를 함유하는 피부상처 치료제의 제조방법
US5240715A (en) Color modified melanins and methods for their preparation and use
US5188844A (en) Color modified melanins and methods for their preparation and use
EP1736170A3 (en) Agent for treating allergic or hypersensitivity condition
US5486353A (en) Antisun product
CA2234936A1 (en) Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20040607

Year of fee payment: 7

LAPS Lapse due to unpaid annual fee